Text Only
Search

 
Avian Flu Vaccine 100 Percent Effective in Pittsburgh Animal Tests


27 February 2006
Skirble Report - Download MP3 - Download (MP3) audio clip
Skirble Report - Download MP3 - Listen (MP3) audio clip
Skirble Report - Download RealAudio - Download (Real) audio clip
Skirble Report - Download RealAudio - Listen (Real) audio clip

Researchers at the University of Pittsburgh have genetically engineered an avian flu vaccine from components of the deadly H5N1 virus.  The Journal of Virology reports that the new vaccine completely protected all mice and chickens immunized against the disease. 

The vaccine combines a live virus that causes the common cold with genetic material from the H5N1 virus and is grown in cells.  This differs from the conventional procedure that uses a dead virus cultured in eggs. 

Dr. Andrea Gambotto, avian flu researcher at the University of Pittsburgh in his laboratory
Dr. Andrea Gambotto, avian flu researcher in his laboratory
Dr. Andrea Gambotto of the University of Pittsburgh Medical School is lead author of the study.  He says the new vaccine offers potentially broader protection than one targeted at a specific flu strain.

"If the virus changes a little bit while you are stockpiling it, you may have to start from scratch to develop another vaccine and maybe you have used up the eggs that culture the vaccine.  You may end up with nothing or be incapable of producing a new one," he says.

The study finds that one form of the recombinant virus creates several types of immunity against the H5N1 virus, making it an attractive candidate to prevent the spread of the disease in poultry and perhaps among humans.  Dr. Gambotto says if a pandemic hit, a strain-specific vaccine could be developed within a month.  "The vaccine can still change a little bit," he says.  "We still think that the vaccine will cover those type of changes."   

Dr. Gambotto expects to begin human clinical trials of the vaccine within six months.  He says the genetic engineering approach offers great promise not just against the H5N1 virus, but against other emerging diseases.  

Dr. Gambotto is optimistic that the vaccine will be effective in humans.  'The only thing that I don't know is how much vaccine I need to give to the people to generate immunity which relates to protection," he says

An estimated 150 to 200 million birds have either died in outbreaks or been killed in an effort to prevent the infection from spreading.  170 people have caught avian flu from infected poultry, and half of them have died.  The virus must first mutate in humans before it can be passed from person to person.

emailme.gif E-mail This Article
printerfriendly.gif Print Version

  Related Stories
Bird Flu Computer Database Helps Scientists Develop a Vaccine
US Health Officials Stress Global Cooperation to Combat Bird Flu
 
  Top Story
Obama, World Leaders Honor Veterans on Anniversary of End WWI

  More Stories
South Korean Military on High Alert After Naval Clash
Clinton Discusses North Korea, Burma Issues at APEC
Obama Pays Tribute to Fort Hood Shooting Victims   Audio Clip Available  Video clip available
Washington Area Sniper Executed
Bomb Rocks Northwestern Pakistan
China Ready to Welcome President Obama  Video clip available
British PM Defends Military Mission in Afghanistan  Audio Clip Available
Lebanon's Unity Government Convenes for First Time
Report: Africa's Disappearing Wetlands Produce 'Alarming' Levels of Greenhouse Gas
IEA Urges Action on Climate Change
Somali Pirates Deny Arms Seizure  Audio Clip Available
Cross-Examination Begins in War Crimes Trial of Former Liberian President  Audio Clip Available
US Development of H1N1 Vaccine Hits Snag  Video clip available
Clinton Urges 'Compassion' for Americans Detained in Iran  Audio Clip Available
World War II Museum Expansion Aims at Younger Generations  Audio Clip Available  Video clip available